Bioactive metabolites from the sponge Suberea sp.

Area of Science:

• Marine Natural Products Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Marine sponges are a rich source of structurally diverse secondary metabolites.
• Brominated natural products often exhibit significant biological activities.
• Suberea species are known producers of bioactive compounds.

Purpose of the Study:

• To isolate and characterize novel brominated compounds from the sponge Suberea sp.
• To evaluate the bioactivities of the isolated compounds, including antimicrobial, cytotoxic, and enzyme inhibition effects.
• To revise the structure of a known compound, subereaphenol B.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
• High-Resolution Mass Spectrometry (HR-MS) for accurate mass determination.
• Bioactivity assays including antimicrobial, cytotoxic, and phosphodiesterase 4 (PDE4) inhibition assays.

Main Results:

• Two new brominated compounds, subereaphenol K (2) and 2-(3,5-dibromo-1-ethoxy-4-oxocyclohexa-2,5-dien-1-yl)acetamide (3), were isolated.
• Subereaphenol B (1) was isolated with a revised structure, along with five other dibromotyrosine-derived metabolites (4-8).
• Compounds 1, 2, 6, and 8 displayed weak to moderate antimicrobial and cytotoxic activities.
• Compounds 1 and 2 demonstrated moderate inhibition of human recombinant phosphodiesterase 4 (PDE4) with IC₅₀ values of 2 μM.

Conclusions:

• The study successfully identified and characterized novel and known brominated metabolites from Suberea sp.
• The isolated compounds, particularly 1 and 2, show promising bioactivities, including PDE4 inhibition, suggesting potential therapeutic applications.
• Further investigation into the structure-activity relationships and mechanisms of action is warranted.